|
Volumn 161, Issue 3, 1994, Pages 246-254
|
Neurotrophic factors and neurologic disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRAIN DERIVED NEUROTROPHIC FACTOR;
CANCER GROWTH FACTOR;
CILIARY NEUROTROPHIC FACTOR;
EPIDERMAL GROWTH FACTOR;
FIBROBLAST GROWTH FACTOR;
GLIA CELL LINE DERIVED NEUROTROPHIC FACTOR;
GROWTH FACTOR RECEPTOR;
LEUKEMIA INHIBITORY FACTOR;
NERVE GROWTH FACTOR;
NERVE GROWTH FACTOR RECEPTOR;
NEUROTROPHIN 3;
NEUROTROPHIN 4;
PACLITAXEL;
RECOMBINANT NERVE GROWTH FACTOR;
SOMATOMEDIN;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANOREXIA;
CELL SURVIVAL;
GROWTH STIMULATION;
HUMAN;
HUMAN CELL;
MOUSE;
NAUSEA;
NERVE CELL DIFFERENTIATION;
NERVE DEGENERATION;
NEUROLOGIC DISEASE;
NONHUMAN;
PATHOGENESIS;
PERIPHERAL NEUROPATHY;
RECEPTOR BINDING;
REVIEW;
ANIMAL;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
NERVOUS SYSTEM DISEASES;
RECEPTORS, NERVE GROWTH FACTOR;
STRUCTURE-ACTIVITY RELATIONSHIP;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
|
EID: 0028657601
PISSN: 00930415
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (34)
|
References (0)
|